| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 52, 370-372, Copyright © 1981 by Endocrine Society
ARTICLES |
WF Crowley Jr, F Comite, W Vale, J Rivier, DL Loriaux and GB Cutler Jr
A two year girl with idiopathic true precocious puberty was treated with a long-acting LHRH agonist, D-Trp6-Pro9-NEt-LHRH (LHRHa). Prior to therapy, the patient demonstrated pulsatile gonadotropin secretion during both night and day, a pubertal response to exogenous LHRH, and an elevated plasma estradiol level. After eight weeks of therapy (4 microgram/kg daily), a mean gonadotropin levels fell to the prepubertal range, there was no evidence of pulsatile discharge of gonadotropins nor any response to exogenous LHRH, and plasma estradiol levels became undetectable. No adverse drug reactions were encountered and all effects of therapy were reversed following cessation of treatment for two months. LHRH analogs may offer a new approach to the therapy of idiopathic precocious puberty and merit further study.
This article has been cited by other articles:
![]() |
A. M. Pasquino, I. Pucarelli, F. Accardo, V. Demiraj, M. Segni, and R. Di Nardo Long-Term Observation of 87 Girls with Idiopathic Central Precocious Puberty Treated with Gonadotropin-Releasing Hormone Analogs: Impact on Adult Height, Body Mass Index, Bone Mineral Content, and Reproductive Function J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 190 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Eugster, W. Clarke, G. B. Kletter, P. A. Lee, E. K. Neely, E. O. Reiter, P. Saenger, D. Shulman, L. Silverman, L. Flood, et al. Efficacy and Safety of Histrelin Subdermal Implant in Children with Central Precocious Puberty: A Multicenter Trial J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1697 - 1704. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Carel, J. Blumberg, C. Seymour, C. Adamsbaum, N. Lahlou, and for the Triptorelin 3-month CPP Study Group Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty Eur. J. Endocrinol., January 1, 2006; 154(1): 119 - 124. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tanaka, H. Niimi, N. Matsuo, K. Fujieda, K. Tachibana, K. Ohyama, M. Satoh, and K. Kugu Results of Long-Term Follow-Up after Treatment of Central Precocious Puberty with Leuprorelin Acetate: Evaluation of Effectiveness of Treatment and Recovery of Gonadal Function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1371 - 1376. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-C. Carel, N. Lahlou, M. Roger, and J. L. Chaussain Precocious puberty and statural growth Hum. Reprod. Update, March 1, 2004; 10(2): 135 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Lee Is Treatment with a Luteinizing Hormone-Releasing Hormone Agonist Justified in Short Adolescents? N. Engl. J. Med., March 6, 2003; 348(10): 942 - 945. [Full Text] [PDF] |
||||
![]() |
M. V. MERICQ, M. EGGERS, A. AVILA, G. B. CUTLER Jr., and F. CASSORLA Near Final Height in Pubertal Growth Hormone (GH)-Deficient Patients Treated with GH Alone or in Combination with Luteinizing Hormone-Releasing Hormone Analog: Results of a Prospective, Randomized Trial J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 569 - 573. [Abstract] [Full Text] |
||||
![]() |
A. Cassio, E. Cacciari, A. Balsamo, M. Bal, and D. Tassinari Randomised trial of LHRH analogue treatment on final height in girls with onset of puberty aged 7.5-8.5 years Arch. Dis. Child., October 1, 1999; 81(4): 329 - 332. [Abstract] [Full Text] |
||||
![]() |
W F Paterson, E McNeill, S Reid, A S Hollman, and M D C Donaldson Efficacy of Zoladex LA (goserelin) in the treatment of girls with central precocious or early puberty Arch. Dis. Child., October 1, 1998; 79(4): 323 - 327. [Abstract] [Full Text] |
||||
![]() |
A. S. Penzias, S. R. Goodman, G. Rossi, F. N. Shamma, R. F. Aten, H. R. Behrman, and E. E. Jones Preliminary Evidence That GnRH Has the Properties of a Growth Hormone-Releasing Factor In Vivo in the Rat Reproductive Sciences, July 1, 1995; 2(4): 623 - 629. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |